A Cluster‐Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence

ConclusionsPatient enrollment will continue through 2016, with results expected in 2019. This study will provide information on whether a distant, centralized CVRS can be implemented in large numbers of medical offices, if it is effective in diverse populations, and if there is a long‐term sustained effect.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - June 25, 2015 Category: Drugs & Pharmacology Authors: Barry L. Carter, Christopher S. Coffey, Elizabeth A. Chrischilles, Gail Ardery, Dixie Ecklund, Brian Gryzlak, Mark W. Vander Weg, Paul A. James, Alan J. Christensen, Christopher P. Parker, Tyler Gums, Rachel J. Finkelstein, Liz Uribe, Linnea A. Polgreen, Tags: Original Research Article Source Type: research